Anzeige
Mehr »
Login
Samstag, 11.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
6 Leser
Artikel bewerten:
(0)

Allscripts named Microsoft's U.S. Health Provider Partner of the Year

CHICAGO, July 31, 2014 /PRNewswire/ --Allscripts (NASDAQ: MDRX) has received the U.S. Health Provider Partner of the Year award from Microsoft Corp. in recognition of Allscripts innovation, collaboration and leadership contributions in the areas of patient and population health.

Microsoft's U.S Health Provider Partner of the Year award recognizes the excellence and achievement of Microsoft industry partners that have produced exceptional results for customers, with a particular focus on impact in the healthcare industry.

"Healthcare needs innovation. Allscripts, with its open initiative, has built a platform to encourage partners to collaborate and innovate," said Steve Aylward, General Manager, US Health & Life Sciences Solutions at Microsoft. "We are pleased to present Allscripts with this recognition and to highlight its exceptional accomplishments for patients, health consumers, providers and the entire healthcare information community."

Allscripts was recognized for the development of its innovative Allscripts Wand' for Windows 8 application for PCs and tablets. Allscripts Wand for Windows is a highly flexible mobile solution that gives users a wide variety of options. It enables choice by giving clinicians the ability to use legacy electronic health records (EHRs) and new EHRs simultaneously on the same device.In addition to the choice of devices, Allscripts Wand for Windows also provides choice of navigation by touch, stylus or mouse.

Allscripts was also honored for its Allscripts FollowMyHealth' patient engagement solution which employs the Microsoft Azure platform. Allscripts FollowMyHealth' allows convenient online access to health information. The portal, which is EHR-agnostic and can be integrated with systems across the enterprise, enables patients or family members to complete digital forms, view test results, refill prescriptions, request appointments, pay bills online and communicate with physicians.

"Allscripts appreciates this recognition of our open platform," said Paul M. Black, President and Chief Executive Officer of Allscripts. "Our unique approach to developers and other innovative sources distinguishes Allscripts in the marketplace and allows clients, patients and innovation to all meet for the improvement of health outcomes."

About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health'. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2014 Allscripts. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are either registered trademarks or trademarks of Allscripts in the United States and/or other countries. All other trademarks are the property of their respective owners.

Allscripts Healthcare Solutions, Inc. Logo.

Logo - http://photos.prnewswire.com/prnh/20100901/CG58147LOGO

SOURCE Allscripts Healthcare Solutions, Inc.

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.